Peter Griffin posted in Adam Patterson • Auckland university • cancer • hypoxia • Jeff Smaill • lung cancer • PR506 • tumour on February 25th, 2011.
Martin Johnston writes in the New Zealand Herald about a ‘stealth’ anti-cancer drug, developed by Auckland University researchers, which is to begin clinical development overseas. The drug, PR509, targets lung tumours while leaving healthy tissue alone: it is activated by the hypoxic (low oxygen) conditions which exist in solid tumours. An excerpt: (read in full [...]
Continue reading “NZ Herald: Foreign teams to work on promising NZ cancer drug”